申请人:eXIthera Pharmaceuticals, Inc.
公开号:US20210188812A1
公开(公告)日:2021-06-24
The present invention provides compounds that inhibit Factor XIa or kallikrein and pharmaceutically acceptable salts thereof and compositions thereof. The present invention also provides methods of using these compounds and compositions.